16 reports

The drug candidate acts by targeting pollen allergen Bet v ##.

  • Allergy Immunotherapy
  • Digestive System Disorder
  • Immunotherapy
  • Product Initiative
  • Anergis SA

PATIENTS WERE RANDOMIZED IN A ##:## FASHION TO ACTIVE DRUG VERSUS PLACEBO.

  • Allergy
  • Allergy Immunotherapy
  • Chronic Disease
  • Digestive System Disorder
  • Aimmune Therapeutics, Inc.

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Allergy Immunotherapy
  • Digestive System Disorder
  • Therapy
  • Aimmune Therapeutics, Inc.

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Allergy Immunotherapy
  • Digestive System Disorder
  • United States
  • Product Initiative

Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy
  • Allergy Drug
  • Allergy Immunotherapy
  • Chronic Disease
  • Digestive System Disorder

Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy
  • Allergy Immunotherapy
  • Biopharmaceutical
  • Chronic Disease
  • Digestive System Disorder

HOUSE DUST MITE ALLERGY - PIPELINE BY STALLERGENES GREER PLC, H## 2019 House Dust Mite Allergy - Drug Profiles ALLERGAN FOR DUST MITE ALLERGY - DRUG PROFILE ALLERGEN FOR ALLERGIC ASTHMA AND HOUSE DUST MITE ALLERGY - DRUG PROFILE AM-## -

  • Allergy
  • Allergy Drug
  • Allergy Immunotherapy
  • Digestive System Disorder
  • Therapy

" House dust mite allergy is one of the most common allergies, impacting the quality of life for patients across ages and geographies.

  • Allergy
  • Allergy Drug
  • Allergy Immunotherapy
  • Digestive System Disorder
  • Therapy

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy Immunotherapy
  • Digestive System Disorder
  • Immunotherapy
  • United States
  • Product Initiative

HALMRE-## - DRUG PROFILE POLLINEX QUATTRO GRASS - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description Pollinex Quattro Grass Allergy Therapeutics Plc NA GlaxoSmithKline Plc R& D Progress Resea

  • Allergy Drug
  • Allergy Immunotherapy
  • Ophthalmic Solution
  • Pharmaceutical
  • Product Initiative

Oneness Biotech Co Ltd (Oneness Biotech) is a biopharmaceutical company that conducts research and development of drugs.

  • Allergy Drug
  • Allergy Immunotherapy
  • Digestive System Disorder
  • Respiratory Disease
  • Glenmark Pharmaceuticals Ltd.

The drug candidate is in Phase II stage for peanut allergy in adults and pediatrics, grass pollen allergy and dermatitis globally.

  • Allergy Immunotherapy
  • Antifungal
  • Digestive System Disorder
  • United States
  • Product Initiative

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Antibiotic Resistance
  • Blood Disease
  • Cancer
  • Digestive System Disorder
  • Bristol-Myers Squibb Company

The drug candidate is in Phase II stage for peanut allergy in adults and pediatrics, grass pollen allergy and dermatitis globally.

  • Allergy Immunotherapy
  • Antifungal
  • Digestive System Disorder
  • Monoclonal Antibody
  • United States

The drug candidate activates allergen-specific T-helper type ## (Th##) cellular responses with the production of interferons by antigen presenting cells (APC), natural killer cells (NK), and T cells.

  • Allergy Drug
  • Allergy Immunotherapy
  • Digestive System Disorder
  • Eye Disease
  • Ophthalmic Solution

Two out of the six were considered possibly related to study drug: one in Group ## and one in Group ##.

  • Antibiotic Resistance
  • Antifungal
  • Digestive System Disorder
  • Infectious Disease
  • SCYNEXIS, Inc.